ArticleBiology direct2025
Galectin-3 directs mitophagy in response to Parkin-/proteasome-dependent rupture of mitochondrial outer membrane.
Article in Biology direct, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Abnormal Galectin Signaling in the Pathomechanisms of Placental Dysfunction in Gestational Diabetes Mellitus.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
PINK1/Parkin-dependent mitophagy is an intracellular process that selectively removes damaged, depolarized mitochondria. In this form of mitophagy, the mitochondrial outer membrane (OMM) undergoes focal rupture through a Parkin- and proteasome-dependent mechanism, which consequently results in the exposure of mitochondrial inner membrane (IMM) mitophagy receptors. The OMM rupture marks the damaged mitochondria and ensures their proper disposal. However, our understanding of the molecular events triggered by OMM rupture remains limited. Here, our proteomic study revealed that Galectin-3, a member of the β-galactoside-binding protein family, is significantly enriched in the ruptured OMM of damaged mitochondria. Galectin-3 is necessary for mitophagy, and it relocalizes from the cytosol to enclose the damaged mitochondria in response to mitophagy induction. The mitochondrial recruitment of Galectin-3 is Parkin- and proteasome-dependent, suggesting that the enclosure of mitochondria by Galectin-3 is a consequence of OMM rupture during PINK1/Parkin-mediated mitophagy. Functionally, Galectin-3 interacts with IMM protein PHB2 and recruits autophagy initiation factors ULK1 on the damaged mitochondria. Importantly, mutations in key residues that confer the liquid-liquid phase separation (LLPS) properties of Galectin-3 abrogates its mitochondrial relocalization, ULK1 recruitment, and mitophagy, suggesting that the capacity to form biomolecular condensates around the damaged mitochondria is crucial for the mitophagy function of Galectin-3. While much of the prior research on Galectin-3 focused on its extracellular functions, our findings shed light on its previously underexplored intracellular functions on the mitochondria and illuminated a novel mechanism by which Galectin-3 senses the damaged mitochondria and maintains organellar quality control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.